Atomoxetine as an adjunct to novel antipsychotic medication in the treatment of cognitive deficits of schizophrenia
Phase of Trial: Phase II
Latest Information Update: 01 Apr 2009
At a glance
- Drugs Atomoxetine (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Pharmacodynamics; Therapeutic Use
- 22 Oct 2007 Status changed from recruiting to in progress.
- 05 Nov 2005 New trial record.